Respiratory stimulant (withdrawn)

Almitrine (with raubasine) (ألميترين)

Almitrine, alone or with raubasine, was used for low oxygen levels in chronic lung disease and for memory and circulation problems linked to ageing. It was withdrawn from European markets because its benefits no longer outweighed its risks, including weight loss and damage to the nerves of the legs.

What it is used for

  • It is no longer recommended for any use
  • It was formerly used for low oxygen in chronic lung disease and for memory problems in older people

How it is used

  • Do not start it and do not use any old supplies you still have
  • If you are still taking it, talk to your doctor about a suitable alternative, and do not stop your other medicines yourself

Possible side effects

  • Weight loss
  • Numbness, tingling or weakness in the legs (peripheral neuropathy)
  • Nausea or indigestion

Who should not use it

  • It should not be used, as it has been withdrawn

Before and while using it

  • Do not buy it from unofficial sources or online
  • Tell your doctor if you have had numbness or weakness in the legs or weight loss after using it

Medicine interactions

  • Ask your pharmacist or doctor about your current medicines when switching to an alternative

Pregnancy and breastfeeding

  • It is not used in pregnancy or breastfeeding

How to store it

  • Return any unused tablets to a pharmacy for safe disposal

Get medical help straight away if

  • Your face, lips or tongue swell, or you find it hard to breathe.
  • You get a severe rash, blistering or peeling skin.
  • A side effect worries you or doesn’t go away: contact your doctor or pharmacist.

Questions about this medicine?

Talk to a doctor by video, or send your question by text.

Source: Standard international medicine references

This guide is general information and doesn’t replace advice from your doctor or pharmacist. Don’t start, stop or change a medicine without asking them, and always read the leaflet in the pack.